Investigating metformin for cancer prevention and treatment: the end of the beginning
about
Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in CancerUnexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsA novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisDysregulated metabolism contributes to oncogenesisWhy does obesity promote cancer? Epidemiology, biology, and open questionsMetformin and thyroid: an updateHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerEpithelial cancers in the post-genomic era: should we reconsider our lifestyle?Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metforminMetformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drugMetformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent BiosynthesisMetformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived XenograftsMATE2 Expression Is Associated with Cancer Cell Response to MetforminObesity and cancer pathogenesis.Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II.Metformin effects on biochemical recurrence and metabolic signaling in the prostate.Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2.Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic reviewWhen less may be more: calorie restriction and response to cancer therapy.From rapalogs to anti-aging formula.CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesityMetformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.Increased oxidative metabolism in the Li-Fraumeni syndromeHyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.Calorie restriction and cancer prevention: a mechanistic perspective.Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.Metformin improves healthspan and lifespan in mice.Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.Syrosingopine sensitizes cancer cells to killing by metforminPotential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signalingFrailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 DiabetesMetformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models.Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapyMetformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseThe Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.
P2860
Q26738550-420F7AFE-ED15-4169-87B8-155B5ABFAB31Q26750845-CBE9CCAA-FD2F-4974-B222-7E9DA5E6F9D0Q26774351-881FFB70-4821-456E-97A1-3596BD32530CQ26784630-0562E78F-891D-4C02-B244-EA0EFFE4082DQ26797301-52F630C4-AE57-4DCC-9BB2-EEB051C51178Q26822045-6F77658B-75A0-40E9-8709-A9E94CBB7505Q27005955-BB5D6BF2-9E12-4AA8-8F8E-AE3D4587E018Q27026428-5C025386-850F-4B02-824A-10F36B6F2766Q28391921-5119E16A-41B7-4DAC-8A34-091887C17374Q28485299-AA909E92-FFA6-4DDF-9824-CFB39BF5C6E8Q28538155-B2B4F382-B5AC-41CE-B463-57EE223CD34FQ28551227-F2D75AFF-C154-48AD-B031-7B60B7B1E643Q28552408-CB060A84-35DB-48F8-831E-EA539FE9FC2EQ28555000-C94791A9-2786-4D81-BFD7-52251DC8A5E0Q30361298-40A9267C-6EB0-4C71-8126-7A7C4E6E5ECDQ30540902-9888B841-0A92-4F46-8F55-C3A4E0DC3073Q30665188-7D088B07-4600-479A-8CD9-8ADAB4EF1668Q33587154-5B0ED8D0-D246-46EC-9F75-C5B6C1E983B5Q33655236-D38087A9-5B43-4AD6-B836-0E37C9436DDDQ33721921-09021645-BF35-4FB1-9746-F3D47F49805DQ33829205-4E4DBCEE-5BBD-4D68-A81A-AFC9442D80DEQ33829461-8F6FC6D6-74CF-4772-93DA-2C299662BFCAQ33890763-F5031129-25FD-4FD3-B5C9-6D3A6C7BCA11Q33971668-D8A1FA37-F2F4-45E1-B955-B40295682EC0Q34008143-6D1F2F02-3EFE-4870-9FAE-ACBF40C0A9A8Q34075636-38D9A712-6861-4601-B832-4A30FC910201Q34258945-DF184687-B643-4D48-99BB-CB51DE8B3ED0Q34334262-E73C6651-EE8F-47B2-8FB2-397A71263236Q34360789-0F567CE8-8045-4F30-97D7-F126282078E4Q34468454-80CCCB5A-4B89-47AE-BCE3-71A4F18D5CF5Q34548130-D529D417-2EA5-4048-9992-7B6ADF1168F9Q34567724-431CB90B-E00C-4C24-A142-9EC98DBCD085Q34684420-CABDE98A-C419-4CD2-9471-7C87A7791544Q34957038-DEA46243-5339-4757-BD1E-32EA40FE442EQ35084900-639B7DAB-3826-40CA-AB45-539681A1FB7FQ35163721-0CC9FE72-3016-47F7-A1AF-B4CFE26BC521Q35368220-4DDFE637-6D29-4860-A4BC-1F15B49D3811Q35550204-23E4F9F3-2EC8-4430-8437-9340B0F913D1Q35600122-A3ED2FD9-0188-4555-B5AF-C0DF991DDD54Q35609517-21C7787D-F3F0-472B-AA5F-B21A545CB9BB
P2860
Investigating metformin for cancer prevention and treatment: the end of the beginning
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Investigating metformin for cancer prevention and treatment: the end of the beginning
@ast
Investigating metformin for cancer prevention and treatment: the end of the beginning
@en
Investigating metformin for cancer prevention and treatment: the end of the beginning
@nl
type
label
Investigating metformin for cancer prevention and treatment: the end of the beginning
@ast
Investigating metformin for cancer prevention and treatment: the end of the beginning
@en
Investigating metformin for cancer prevention and treatment: the end of the beginning
@nl
prefLabel
Investigating metformin for cancer prevention and treatment: the end of the beginning
@ast
Investigating metformin for cancer prevention and treatment: the end of the beginning
@en
Investigating metformin for cancer prevention and treatment: the end of the beginning
@nl
P1433
P1476
Investigating metformin for cancer prevention and treatment: the end of the beginning
@en
P2093
M. N. Pollak
P304
P356
10.1158/2159-8290.CD-12-0263
P407
P577
2012-09-01T00:00:00Z